(Q35761726)

10 August 2017

1 reference

title

Endothelial dysfunction in patients with type 2 diabetes and the effects of thiazolidinedione antidiabetic agents (English)

1 reference

10 August 2017

0 references

1 reference

Paresh Dandona

1

1 reference

10 August 2017

Ahmad Aljada

series ordinal

2

1 reference

10 August 2017

language of work or name

1 reference

1 March 2004

1 reference

Journal of Diabetes and its Complications

10 August 2017

published in

1 reference

10 August 2017

volume

18

1 reference

10 August 2017

issue

2

1 reference

10 August 2017

page(s)

91-102

1 reference

Endothelial dysfunction in endocrine disease

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Effect of insulin on human aortic endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Nuclear Factor- B Suppressive and Inhibitor- B Stimulatory Effects of Troglitazone in Obese Patients with Type 2 Diabetes: Evidence of an Antiinflammatory Action?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Diabetes and endothelial dysfunction: a clinical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Diabetes mellitus: a hypercoagulable state

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Endothelial cell adhesion molecule expression and lymphocyte adhesion to endothelial cells: effect of nitric oxide.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Insulin action is associated with endothelial function in hypertension and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Insulin-mediated vasodilation and glucose uptake are functionally linked in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Effects of troglitazone on in vitro oxidation of LDL and HDL induced by copper ions and endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Cerebral blood flow in diabetes mellitus: evidence of abnormal cerebrovascular reactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Instability of cerebral blood-flow in insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Oxidative damage to DNA in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Troglitazone, but not rosiglitazone, inhibits Na/H exchange activity and proliferation of macrovascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Effects of insulin on in vitro vascular cell adhesion molecule-1 expression and in vivo soluble VCAM-1 release.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Pathogenesis of NIDDM. A balanced overview

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alpha-tocopherol supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Circulating endothelin-1 levels in type 2 diabetic patients with ischaemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Flow-dependent coronary artery dilatation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Troglitazone treatment increases plasma vascular endothelial growth factor in diabetic patients and its mRNA in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Troglitazone reduces reactive oxygen species generation by leukocytes and lipid peroxidation and improves flow-mediated vasodilatation in obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Workshop: endothelial cell dysfunction leading to diabetic nephropathy : focus on nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Insulin attenuates norepinephrine-induced venoconstriction. An ultrasonographic study.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Carotid artery atherosclerosis in type-2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (The Insulin Resistance Atherosclerosis Study)

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Endogenous insulin and insulin sensitivity. An important determinant of skeletal muscle blood flow in chronic heart failure?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARgamma in endothelial function.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

The WHO Multinational Study of Vascular Disease in Diabetes: 2. Macrovascular Disease Prevalence

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Endothelial function and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Insulin resistance and its treatment by thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Molecular bases of the acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

1993 Mack Forster Award Lecture. Review. The endothelium as a target and mediator of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Chronic blockade of NO synthase activity induces a proinflammatory phenotype in the arterial wall: prevention by angiotensin II antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Loss of flow-mediated endothelium-dependent dilation occurs early in the development of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Response of experimental retinal neovascularization to thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Differential regulation by troglitazone of plasminogen activator inhibitor type 1 in human hepatic and vascular cells

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Low-density lipoprotein size, high-density lipoprotein concentration, and endothelial dysfunction in non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Inhibitory effect of troglitazone on TNF-alpha-induced expression of monocyte chemoattractant protein-1 (MCP-1) in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Effect of gliclazide on monocyte-endothelium interactions in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial function.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Microvascular function relates to insulin sensitivity and blood pressure in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Insulin-mediated venodilation is impaired in patients with high cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

The association between insulin resistance and endotheliopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

The vasodilating effect of insulin is dependent on local glucose uptake: a double blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Insulin therapy improves endothelial function in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Effect of a single high-fat meal on endothelial function in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Troglitazone improves endothelial dysfunction in patients with insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Elevated serum TNF-alpha level as a link between endothelial dysfunction and insulin resistance in normotensive obese patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900259-3

7 January 2021

10.1016/S1056-8727(02)00259-3

Identifiers

DOI

1 reference

10 August 2017

1 reference